On Monday, the “de-extinction” startup Colossal Biosciences announced its most ambitious results to date: the dire wolf.

Colossal Biosciences claims it has revived an extinct species, but scientists outside the company are skeptical.

The dire wolf has been resurrected in a remarkable achievement by Texas-based biotechnology company Colossal Biosciences.

Using CRISPR-Cas9 edited iPSC-derived MN models ... Input = 4% of total protein used in co immunoprecipitation. (C) Venn diagram: all identified proteins from each DNAJC7 IP (n=3), 88 of which ...

A longstanding mystery in Parkinson's disease research has been why some individuals carrying pathogenic variants that increase their risk of PD go on to develop the disease, while others who also ...

New CRISPR tool enables more seamless gene editing -- and improved disease modeling Date: March 20, 2025 Source: Yale University Summary: Advances in the gene-editing technology known as CRISPR ...

Advances in the gene-editing technology known as CRISPR-Cas9 over the past 15 years have yielded important new insights into the roles that specific genes play in many diseases. But to date this ...

Advances in the gene-editing technology known as CRISPR-Cas9 over the past 15 years have yielded important new insights into the roles that specific genes play in many diseases. But to date this ...

Here's why they picked CRISPR Therapeutics (NASDAQ: CRSP), Summit Therapeutics (NASDAQ: SMMT), and Viking Therapeutics (NASDAQ: VKTX) as stocks worth buying now. Prosper Junior Bakiny (CRISPR ...